Howard Cyr Email & Phone Number

Wayne, Pa, Us

The Chief Compliance Officer oversees and manages compliance issues within Teleflex to ensure that the Company is in compliance with various regulatory requirements and that its employees are in adherence with internal procedures and policies.

Wayne, Pa, Us

Responsible for managing risk exposure and litigation, claims, and other disputes involving the organization on a global basis at this medical device company , including overseeing and managing outside counsel, monitoring and managing legal expense, overseeing discovery and providing advice to assist the company in managing and mitigating litigation risk.

Tel-Aviv, Il

Managed risk exposure and litigation at this global pharmaceutical firm associated with commercial and IP disputes, product liability and clinical trials involving innovative and generic drugs. Counseled R&D, regulatory, medical/scientific and pharmacovigilance executive board as well as quality and technical operations committee to manage emerging regulatory, compliance, and safety risks involving labeling and promotional practices, recalls, clinical trials and post-marketing safety obligations. Counseled commercial, corporate communications, environmental, insurance, and information record units. Negotiated and resolved commercial disputes involving research and development, supply and distribution, and breach of patent settlements. • Investigated and favorably settled for $27.6 million DOJ criminal and civil investigation of Company’s promotional practices and compliance with FDA regulations and fraud and abuse laws with no criminal charges filed.• Developed risk management training and education for internal corporate communications.• Implemented and refined litigation hold, and record and information management policies and program.• Developed global product liability risk mitigation initiative in coordination with Company enterprise risk management program.• Managed regulatory and labeling strategy with foreign health authorities regarding reanalysis of adverse event data.• Led and successfully resolved international litigation, regulatory, IP, commercial, compliance, governance, communications, and employment issues arising out of Company’s multi-billion dollar acquisition of a foreign pharmaceutical company.• In matter associated with regulatory issues re toxicology classification of oncology drug, successfully recovered $55 million in UK courts dispute with contract manufacturer. • Led and successfully recovered $340 million in 10 highly contested London arbitrations involving damages from patent infringement.

Exton, Pa, Us

Responsible for overall legal function of this cell and gene therapy company including risk management, compliance, strategic alliances with academic research centers, intellectual property strategy, and corporate governance. Counseled on regulatory requirements and promotion of Company’s first approved product, Laviv® (azficel-T), an autologous aesthetic cell therapy approved by FDA Biologics License Agreement for improvement of nasolabial folds.

New York, New York, Us

Responsible for management of risk exposure and litigation associated with small-molecule drugs, biologics, vaccines, and clinical trials. Prepared 10-K and 10-Q securities filings for contingent loss liabilities and FASB-5 report for public auditors. Counseled commercial, communications, research, information technology, and pharmacovigilance units. • Managed and defended litigation and National Vaccine Injury Compensation Program claims arising out of company’s polio vaccines and Prevnar® vaccine.• Developed risk management communications and training for internal corporate communications.• Coordinated response to government inquiries and subpoenas regarding product promotional and marketing practices.• Deployed strategy to defend legal claims brought by third party payors seeking reimbursement for drug withdrawn from market due to safety issues.• Contained litigation threat attacking some of Company’s preeminent products (Effexor® and Enbrel®) resulting in significant reduction of legal and financial exposure to Company.

Bachelor Of Arts; Honors, History

Juris Doctor